FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

12 letters match. Newest first.

  1. PolleyMed, LLC

    FDA says PolleyMed's SaniiSwab nasal swab is an unapproved, misbranded drug sold online with infection-prevention claims and a false FDA approval claim.

    High risk
  2. Meamo

    Meamo's website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers, FDA says.

    High risk
  3. Bio Wellness 444 LLC

    Bio Wellness 444 sold Silver Bullet and Silver D douches as unapproved new drugs for vaginal infections.

    High risk
  4. Cosco International, Inc.

    FDA warned Cosco International over nonprescription drug manufacturing failures and unapproved drug products.

    High risk
  5. Dexterity Health, LLC DBA Zazzee Naturals

    Zazzee Naturals sells Liquid MSM eye drops online as an unapproved new drug, FDA says in warning letter.

    High risk
  6. Osmosis, LLC

    Osmosis sold unapproved drug products with disease claims and had dietary supplement CGMP and labeling violations.

    High risk
  7. Kleenhanz, LLC

    FDA told Kleenhanz its antiseptic towelettes were unapproved drugs because the website and Twitter claimed they fight COVID-19 and other diseases.

    High risk
  8. Eagle Energy USA, Inc.

    FDA warned Eagle Energy USA that its inhalable Caffeine Pen products are unapproved new drugs with safety concerns.

    High risk
  9. VitaCig, Inc.

    FDA warned VitaCig that its flavored inhalers and capsules are unapproved new drugs sold with disease-treatment claims on its website.

    High risk
  10. Disinfect & Shield

    FDA warned Disinfect & Shield that its non-alcohol hand sanitizer was an unapproved drug sold with COVID-19 and long-lasting efficacy claims.

    High risk
  11. American Specialty Pharmacy, Inc. dba ASP Cares

    FDA warned outsourcing facility ASP Cares about sterile compounded drugs made under insanitary conditions and with CGMP violations.

    High risk
  12. Maison Terre, LLC

    FDA says Maison Terre repacked Goldenseal Root Powder under insanitary conditions with microbial contamination and sold unapproved drug products.

    High risk